Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 2 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 3 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 4 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 5 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 6 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 7 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 8 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 9 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 10 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 11 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 12 of 13

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies — Image 13 of 13

3D model · NIH 3D

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies

Platform: NIH 3D
Price: Free
License: CC-BY; Print, modify and use commercially — credit the author.
Formats: WRLSTLX3DGLB

10 Downloads
172 Views

Author:cruzp2

Published 2020-11-16

Description

PDB Classifiation: VIRAL PROTEIN/IMMUNE SYSTEM

Tags

antiviral viral protein-immune system complex sars-cov-2 covid-19 therapeutic antibody cricetulus griseus

More like this

Similar models

Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing antibody, CV30 Fab

Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing antibody, CV30 Fab

Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab

Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab

Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2)

Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2)

Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)

Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)

Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody

Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody

Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022

Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022

Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab

Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab

S protein of SARS-CoV-2 in complex bound with 4A8

S protein of SARS-CoV-2 in complex bound with 4A8

Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex with EY6A Fab and a nanobody.

Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex with EY6A Fab and a nanobody.

Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab

Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab

Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD

Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD

Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72

Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72

Names are used only to indicate the source of a result. Polyzon is not affiliated with the listed sites.